nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—respiratory system—chronic obstructive pulmonary disease	0.0264	0.257	CbGeAlD
Travoprost—PTGFR—bronchus—chronic obstructive pulmonary disease	0.0218	0.211	CbGeAlD
Travoprost—PTGFR—smooth muscle tissue—chronic obstructive pulmonary disease	0.0213	0.207	CbGeAlD
Travoprost—PTGFR—trachea—chronic obstructive pulmonary disease	0.0195	0.19	CbGeAlD
Travoprost—PTGFR—lung—chronic obstructive pulmonary disease	0.014	0.136	CbGeAlD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0127	0.355	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00311	0.0867	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00228	0.0636	CbGpPWpGaD
Travoprost—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00202	CcSEcCtD
Travoprost—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.00202	CcSEcCtD
Travoprost—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.00202	CcSEcCtD
Travoprost—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00201	CcSEcCtD
Travoprost—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.00201	CcSEcCtD
Travoprost—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00173	0.00201	CcSEcCtD
Travoprost—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.002	CcSEcCtD
Travoprost—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.002	CcSEcCtD
Travoprost—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00173	0.002	CcSEcCtD
Travoprost—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.002	CcSEcCtD
Travoprost—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00172	0.00199	CcSEcCtD
Travoprost—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00197	CcSEcCtD
Travoprost—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00169	0.00196	CcSEcCtD
Travoprost—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00196	CcSEcCtD
Travoprost—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00196	CcSEcCtD
Travoprost—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00196	CcSEcCtD
Travoprost—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00195	CcSEcCtD
Travoprost—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00195	CcSEcCtD
Travoprost—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00195	CcSEcCtD
Travoprost—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.00195	CcSEcCtD
Travoprost—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00195	CcSEcCtD
Travoprost—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00193	CcSEcCtD
Travoprost—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00193	CcSEcCtD
Travoprost—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.0019	CcSEcCtD
Travoprost—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00189	CcSEcCtD
Travoprost—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00189	CcSEcCtD
Travoprost—Cataract—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00188	CcSEcCtD
Travoprost—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00188	CcSEcCtD
Travoprost—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00185	CcSEcCtD
Travoprost—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00185	CcSEcCtD
Travoprost—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00184	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00183	CcSEcCtD
Travoprost—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00182	CcSEcCtD
Travoprost—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00155	0.0018	CcSEcCtD
Travoprost—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.0018	CcSEcCtD
Travoprost—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00177	CcSEcCtD
Travoprost—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00176	CcSEcCtD
Travoprost—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00176	CcSEcCtD
Travoprost—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.00175	CcSEcCtD
Travoprost—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00174	CcSEcCtD
Travoprost—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00174	CcSEcCtD
Travoprost—Cough—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00174	CcSEcCtD
Travoprost—Cough—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00174	CcSEcCtD
Travoprost—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00172	CcSEcCtD
Travoprost—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00172	CcSEcCtD
Travoprost—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00172	CcSEcCtD
Travoprost—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00172	CcSEcCtD
Travoprost—Cough—Montelukast—chronic obstructive pulmonary disease	0.00147	0.0017	CcSEcCtD
Travoprost—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.0017	CcSEcCtD
Travoprost—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00169	CcSEcCtD
Travoprost—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00169	CcSEcCtD
Travoprost—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00169	CcSEcCtD
Travoprost—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00169	CcSEcCtD
Travoprost—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00169	CcSEcCtD
Travoprost—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00169	CcSEcCtD
Travoprost—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00169	CcSEcCtD
Travoprost—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00169	CcSEcCtD
Travoprost—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00169	CcSEcCtD
Travoprost—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00169	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00168	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00168	CcSEcCtD
Travoprost—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00167	CcSEcCtD
Travoprost—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00167	CcSEcCtD
Travoprost—PTGFR—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00143	0.0399	CbGpPWpGaD
Travoprost—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00166	CcSEcCtD
Travoprost—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00166	CcSEcCtD
Travoprost—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00166	CcSEcCtD
Travoprost—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00166	CcSEcCtD
Travoprost—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00166	CcSEcCtD
Travoprost—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00165	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00165	CcSEcCtD
Travoprost—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00165	CcSEcCtD
Travoprost—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00164	CcSEcCtD
Travoprost—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00162	CcSEcCtD
Travoprost—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00162	CcSEcCtD
Travoprost—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00162	CcSEcCtD
Travoprost—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00161	CcSEcCtD
Travoprost—Infection—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00161	CcSEcCtD
Travoprost—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0016	CcSEcCtD
Travoprost—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0016	CcSEcCtD
Travoprost—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0016	CcSEcCtD
Travoprost—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00159	CcSEcCtD
Travoprost—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00158	CcSEcCtD
Travoprost—Infection—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00158	CcSEcCtD
Travoprost—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00158	CcSEcCtD
Travoprost—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00158	CcSEcCtD
Travoprost—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00135	0.00157	CcSEcCtD
Travoprost—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00157	CcSEcCtD
Travoprost—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00156	CcSEcCtD
Travoprost—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00155	CcSEcCtD
Travoprost—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00153	CcSEcCtD
Travoprost—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00152	CcSEcCtD
Travoprost—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00152	CcSEcCtD
Travoprost—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00152	CcSEcCtD
Travoprost—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00151	CcSEcCtD
Travoprost—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0015	CcSEcCtD
Travoprost—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.0015	CcSEcCtD
Travoprost—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00149	CcSEcCtD
Travoprost—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00148	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00148	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00148	CcSEcCtD
Travoprost—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00146	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00145	CcSEcCtD
Travoprost—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00145	CcSEcCtD
Travoprost—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00145	CcSEcCtD
Travoprost—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00143	CcSEcCtD
Travoprost—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00143	CcSEcCtD
Travoprost—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00143	CcSEcCtD
Travoprost—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00142	CcSEcCtD
Travoprost—Injury—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00142	CcSEcCtD
Travoprost—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00141	CcSEcCtD
Travoprost—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0014	CcSEcCtD
Travoprost—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0014	CcSEcCtD
Travoprost—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00121	0.0014	CcSEcCtD
Travoprost—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0014	CcSEcCtD
Travoprost—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0014	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.0014	CcSEcCtD
Travoprost—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00139	CcSEcCtD
Travoprost—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00139	CcSEcCtD
Travoprost—Pain—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00139	CcSEcCtD
Travoprost—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00139	CcSEcCtD
Travoprost—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00137	CcSEcCtD
Travoprost—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00137	CcSEcCtD
Travoprost—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00137	CcSEcCtD
Travoprost—Pain—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00136	CcSEcCtD
Travoprost—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00135	CcSEcCtD
Travoprost—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00135	CcSEcCtD
Travoprost—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00134	CcSEcCtD
Travoprost—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00134	CcSEcCtD
Travoprost—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00134	CcSEcCtD
Travoprost—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00134	CcSEcCtD
Travoprost—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00134	CcSEcCtD
Travoprost—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00133	CcSEcCtD
Travoprost—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00133	CcSEcCtD
Travoprost—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00133	CcSEcCtD
Travoprost—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00132	CcSEcCtD
Travoprost—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00132	CcSEcCtD
Travoprost—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00131	CcSEcCtD
Travoprost—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00131	CcSEcCtD
Travoprost—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0013	CcSEcCtD
Travoprost—PTGFR—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.00112	0.0312	CbGpPWpGaD
Travoprost—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00128	CcSEcCtD
Travoprost—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00128	CcSEcCtD
Travoprost—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00127	CcSEcCtD
Travoprost—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00127	CcSEcCtD
Travoprost—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00127	CcSEcCtD
Travoprost—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00126	CcSEcCtD
Travoprost—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00126	CcSEcCtD
Travoprost—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00126	CcSEcCtD
Travoprost—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00126	CcSEcCtD
Travoprost—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00125	CcSEcCtD
Travoprost—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00121	CcSEcCtD
Travoprost—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.0012	CcSEcCtD
Travoprost—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00103	0.0012	CcSEcCtD
Travoprost—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.0012	CcSEcCtD
Travoprost—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00119	CcSEcCtD
Travoprost—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00117	CcSEcCtD
Travoprost—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.001	0.00117	CcSEcCtD
Travoprost—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00117	CcSEcCtD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000992	0.0276	CbGpPWpGaD
Travoprost—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00115	CcSEcCtD
Travoprost—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00115	CcSEcCtD
Travoprost—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000983	0.00114	CcSEcCtD
Travoprost—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000973	0.00113	CcSEcCtD
Travoprost—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000969	0.00113	CcSEcCtD
Travoprost—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000957	0.00111	CcSEcCtD
Travoprost—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000957	0.00111	CcSEcCtD
Travoprost—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000948	0.0011	CcSEcCtD
Travoprost—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000937	0.00109	CcSEcCtD
Travoprost—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.00109	CcSEcCtD
Travoprost—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000928	0.00108	CcSEcCtD
Travoprost—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00107	CcSEcCtD
Travoprost—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00107	CcSEcCtD
Travoprost—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000906	0.00105	CcSEcCtD
Travoprost—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.00105	CcSEcCtD
Travoprost—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000882	0.00102	CcSEcCtD
Travoprost—Rash—Formoterol—chronic obstructive pulmonary disease	0.000882	0.00102	CcSEcCtD
Travoprost—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000881	0.00102	CcSEcCtD
Travoprost—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000881	0.00102	CcSEcCtD
Travoprost—Headache—Formoterol—chronic obstructive pulmonary disease	0.000876	0.00102	CcSEcCtD
Travoprost—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000876	0.00102	CcSEcCtD
Travoprost—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000875	0.00102	CcSEcCtD
Travoprost—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.00101	CcSEcCtD
Travoprost—Rash—Montelukast—chronic obstructive pulmonary disease	0.000864	0.001	CcSEcCtD
Travoprost—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000863	0.001	CcSEcCtD
Travoprost—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000861	0.001	CcSEcCtD
Travoprost—Depression—Prednisone—chronic obstructive pulmonary disease	0.000861	0.001	CcSEcCtD
Travoprost—Headache—Montelukast—chronic obstructive pulmonary disease	0.000858	0.000997	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00085	0.0237	CbGpPWpGaD
Travoprost—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000837	0.000972	CcSEcCtD
Travoprost—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000834	0.000969	CcSEcCtD
Travoprost—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.000967	CcSEcCtD
Travoprost—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.000966	CcSEcCtD
Travoprost—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000831	0.000965	CcSEcCtD
Travoprost—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000831	0.000965	CcSEcCtD
Travoprost—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.000961	CcSEcCtD
Travoprost—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000814	0.000945	CcSEcCtD
Travoprost—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000801	0.000931	CcSEcCtD
Travoprost—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000789	0.000916	CcSEcCtD
Travoprost—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.000911	CcSEcCtD
Travoprost—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000781	0.000907	CcSEcCtD
Travoprost—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000761	0.000884	CcSEcCtD
Travoprost—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000758	0.00088	CcSEcCtD
Travoprost—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000739	0.000859	CcSEcCtD
Travoprost—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000724	0.000841	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000719	0.0201	CbGpPWpGaD
Travoprost—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000703	0.000816	CcSEcCtD
Travoprost—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.0007	0.000813	CcSEcCtD
Travoprost—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000679	0.000788	CcSEcCtD
Travoprost—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000675	0.000783	CcSEcCtD
Travoprost—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000648	0.000752	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000647	0.018	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000643	0.0179	CbGpPWpGaD
Travoprost—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000636	0.000738	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000629	0.0175	CbGpPWpGaD
Travoprost—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000626	0.000727	CcSEcCtD
Travoprost—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000624	0.000725	CcSEcCtD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000622	0.0173	CbGpPWpGaD
Travoprost—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000608	0.000706	CcSEcCtD
Travoprost—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000704	CcSEcCtD
Travoprost—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000582	0.000676	CcSEcCtD
Travoprost—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000574	0.000667	CcSEcCtD
Travoprost—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000574	0.000667	CcSEcCtD
Travoprost—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000665	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00057	0.000662	CcSEcCtD
Travoprost—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000567	0.000659	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000563	0.0157	CbGpPWpGaD
Travoprost—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000558	0.000648	CcSEcCtD
Travoprost—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000551	0.000639	CcSEcCtD
Travoprost—Infection—Prednisone—chronic obstructive pulmonary disease	0.000547	0.000635	CcSEcCtD
Travoprost—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00054	0.000627	CcSEcCtD
Travoprost—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000537	0.000624	CcSEcCtD
Travoprost—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000535	0.000621	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000533	0.0149	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00053	0.0148	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000502	0.000583	CcSEcCtD
Travoprost—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.000582	CcSEcCtD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000486	0.0136	CbGpPWpGaD
Travoprost—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000485	0.000563	CcSEcCtD
Travoprost—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.000555	CcSEcCtD
Travoprost—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000477	0.000554	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000476	0.0133	CbGpPWpGaD
Travoprost—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000475	0.000551	CcSEcCtD
Travoprost—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.000551	CcSEcCtD
Travoprost—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000471	0.000547	CcSEcCtD
Travoprost—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000527	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000454	0.0126	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00045	0.000523	CcSEcCtD
Travoprost—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00045	0.000523	CcSEcCtD
Travoprost—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000435	0.000505	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000417	0.0116	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000412	0.0115	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000406	0.0113	CbGpPWpGaD
Travoprost—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000471	CcSEcCtD
Travoprost—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000395	0.000459	CcSEcCtD
Travoprost—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000452	CcSEcCtD
Travoprost—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000437	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000366	0.0102	CbGpPWpGaD
Travoprost—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000423	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000363	0.0101	CbGpPWpGaD
Travoprost—Rash—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000403	CcSEcCtD
Travoprost—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000403	CcSEcCtD
Travoprost—Headache—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000401	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000332	0.00926	CbGpPWpGaD
Travoprost—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00038	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000321	0.00895	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000317	0.00885	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000257	0.00718	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000254	0.00708	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000243	0.00678	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000229	0.0064	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000208	0.00581	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000205	0.00571	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000196	0.00547	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000196	0.00547	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000195	0.00544	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000186	0.00519	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000179	0.005	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000163	0.00454	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000143	0.004	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000133	0.00372	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000123	0.00343	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000111	0.00309	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00011	0.00307	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000101	0.0028	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.99e-05	0.00279	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.62e-05	0.00268	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.94e-05	0.00249	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.35e-05	0.00205	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.02e-05	0.00196	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.7e-05	0.00187	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.94e-05	0.00166	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.65e-05	0.00158	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.37e-05	0.0015	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.83e-05	0.00135	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.43e-05	0.00124	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.34e-05	0.00121	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.65e-05	0.00102	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.34e-05	0.000931	CbGpPWpGaD
